ISS/SIC
Journal (WJS)
Congress
Create Account
Login
International Society of Surgery (ISS)
Société Internationale de Chirurgie (SIC)
Integrated Societies: IATSIC | IASMEN | BSI | ISDS
THELDENIYA TECHNIQUE OF ENDOSCOPIC THERMO-ABLATION (TETA) FOR ESOPHAGEAL CANCER
kosala.medi@gmail.com
 
Back
Slot ID
311-03
Abstract Title
THELDENIYA TECHNIQUE OF ENDOSCOPIC THERMO-ABLATION (TETA) FOR ESOPHAGEAL CANCER
Author Details
No. of Authors
2
Including the presenting author
Author 1
Kosala Somaratne kosala.medi@gmail.com District Base Hospital Theldeniya Surgery Theldeniya Sri Lanka *
Author 2
Thilanka Seneviratne thilanka.medi@gmail.com Faculty of Medicine, University of Peradeniya Pharmacology Peradeniya Sri Lanka
Author 3
Author 4
Author 5
Author 6
Author 7
Author 8
Author 9
Author 10
Author 11
Author 12
Presenting Author Name
Kosala Somaratne
Presenting Author Email
kosala.medi@gmail.com
Presenting Author Country
Sri Lanka
Abstract
Abstract type
Oral or Poster
Introduction *
This new technique was devised to alleviate dysphagia in a) patients on palliation who are not amenable to stents due to very tight stricture b) patients who refuses surgery and other oncologic treatments c) patients in the work up, awaiting surgery
Material & Method *
Malignant tissues were ablated using the endoscopic hot biopsy forceps keeping diathermy in SoftCoag 90watt settings. Channel is coagulated through the obstructing tumor. All patients were scored as per Functional Oral Intake scale (FIOS), pre-TETA and post-TETA. FIOS score 1-7, 1-total dysphagia. 7-no dysphagia, Patients who were on palliation were stented using covered stents after achieving adequate channel diameter
Results *
From July/2024 to July/2025 fourteen (14) patients underwent TETA. 11 on palliative pathway and 03 on pre-op work-up. All patients climbed at least two points in FIOS scale after TETA One patient remarkably climbed from 01 to 07 (i.e. from total dysphagia to no dysphagia at all). No patient had any esophageal perforation. Two patients underwent laparo-thoracoscopic esophagectomy (both without neo-adjuvant chemo-radiation as decided in MDT). Interestingly one patient had surgical specimen histology negative for malignancy, possibly pointing to TETA having a therapeutic value as well. This particular result if supported by further evaluations would be a possible breakthrough in the management of esophageal cancer.
Conclusion *
TETA achieved good relief from dysphagia both in therapeutic and palliative settings in patients who were not amenable to esophageal stenting. There are early indications towards possible therapeutic value of TETA, which needs further evaluation.
File Upload #1
https://storage.unitedwebnetwork.com/files/1258/e91c74a2c2d3e26fc7ea8434c08ab6be.jpg
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
File Upload #2
https://storage.unitedwebnetwork.com/files/1258/d2f62d92a3c36d01b4caba9713bc27bd.jpg
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
Category
Select Main Category
2 Digestive Surgery organized by ISDS
Select Sub Category
2.01 Upper Gastro-Intestinal Surgery
Submission Status
Submitted
Word counter
240
Abstract Prizes
Eligible for the BSI Free Paper Prize
No
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript conforming to the format of orignial articles in the World Journal of Surgery WJS by 30 November 2025
Eligible for the Grassi Prize
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
Eligible for the Kitajima Prize
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
Vimeo Link